Camurus AB (publ) (CAMRF)
USD 59.98
(0.01%)
USD 59.98
(0.01%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.59 Billion SEK | 86.91% |
| 2022 | 853.07 Million SEK | 65.58% |
| 2021 | 515.21 Million SEK | 71.33% |
| 2020 | 300.71 Million SEK | 265.31% |
| 2019 | 82.31 Million SEK | 93.69% |
| 2018 | 42.49 Million SEK | -19.74% |
| 2017 | 52.95 Million SEK | -52.55% |
| 2016 | 111.59 Million SEK | -27.8% |
| 2015 | 154.56 Million SEK | -25.53% |
| 2014 | 207.55 Million SEK | 5.82% |
| 2013 | 196.14 Million SEK | 113.47% |
| 2012 | 91.88 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 409.31 Million SEK | 13.98% |
| 2024 Q1 | 359.11 Million SEK | 5.01% |
| 2023 Q3 | 351.99 Million SEK | -45.45% |
| 2023 FY | 1.59 Billion SEK | 86.91% |
| 2023 Q4 | 341.99 Million SEK | -2.84% |
| 2023 Q2 | 645.27 Million SEK | 152.81% |
| 2023 Q1 | 255.24 Million SEK | 6.34% |
| 2022 Q1 | 194.09 Million SEK | 25.52% |
| 2022 FY | 853.07 Million SEK | 65.58% |
| 2022 Q3 | 217.33 Million SEK | 7.79% |
| 2022 Q4 | 240.02 Million SEK | 10.44% |
| 2022 Q2 | 201.61 Million SEK | 3.87% |
| 2021 Q3 | 133.05 Million SEK | 13.43% |
| 2021 Q4 | 154.63 Million SEK | 16.22% |
| 2021 FY | 515.21 Million SEK | 71.33% |
| 2021 Q1 | 110.22 Million SEK | 18.41% |
| 2021 Q2 | 117.3 Million SEK | 6.42% |
| 2020 Q1 | 41.51 Million SEK | 93.25% |
| 2020 FY | 300.71 Million SEK | 265.31% |
| 2020 Q4 | 93.08 Million SEK | 3.87% |
| 2020 Q3 | 89.61 Million SEK | 17.15% |
| 2020 Q2 | 76.49 Million SEK | 84.26% |
| 2019 Q4 | 21.48 Million SEK | -39.32% |
| 2019 Q1 | 15.49 Million SEK | 300.65% |
| 2019 Q2 | 9.93 Million SEK | -35.91% |
| 2019 Q3 | 35.4 Million SEK | 256.48% |
| 2019 FY | 82.31 Million SEK | 93.69% |
| 2018 Q2 | 6.09 Million SEK | -53.42% |
| 2018 FY | 42.49 Million SEK | -19.74% |
| 2018 Q4 | 3.86 Million SEK | -80.1% |
| 2018 Q3 | 19.44 Million SEK | 218.81% |
| 2018 Q1 | 13.09 Million SEK | 178.32% |
| 2017 FY | 52.95 Million SEK | -52.55% |
| 2017 Q3 | 13.05 Million SEK | -27.65% |
| 2017 Q4 | 4.7 Million SEK | -63.95% |
| 2017 Q1 | 17.16 Million SEK | -52.2% |
| 2017 Q2 | 18.03 Million SEK | 5.11% |
| 2016 Q1 | 20.18 Million SEK | -44.3% |
| 2016 FY | 111.59 Million SEK | -27.8% |
| 2016 Q3 | 29.98 Million SEK | 17.45% |
| 2016 Q4 | 35.89 Million SEK | 19.72% |
| 2016 Q2 | 25.53 Million SEK | 26.5% |
| 2015 Q2 | 22.68 Million SEK | -61.25% |
| 2015 Q1 | 58.54 Million SEK | -59.56% |
| 2015 Q3 | 37.1 Million SEK | 63.54% |
| 2015 Q4 | 36.23 Million SEK | -2.33% |
| 2015 FY | 154.56 Million SEK | -25.53% |
| 2014 Q4 | 144.74 Million SEK | 324.72% |
| 2014 Q3 | 34.08 Million SEK | 0.0% |
| 2014 FY | 207.55 Million SEK | 5.82% |
| 2013 FY | 196.14 Million SEK | 113.47% |
| 2012 FY | 91.88 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 9.61 Million USD | -16490.386% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 1283391.08% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | -1238.707% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 499150.725% |
| Qrons Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 3304151.058% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | 65375335.752% |
| BioStem Technologies, Inc. | 15.42 Million USD | -10237.231% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -902993.566% |
| CSL Limited | 7.56 Billion USD | 78.911% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 6280.719% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -13521.237% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -1134776.868% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -10530.722% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -51402285.558% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | -16180.396% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -2425809.81% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 4669212.738% |
| Mesoblast Limited | -35.16 Million USD | 4633.957% |
| Marizyme, Inc. | 457.7 Thousand USD | -348271.211% |
| Genus plc | 178.7 Million USD | -792.279% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | -624.431% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -2562336.923% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -388646.48% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 14495572.727% |
| ContraFect Corporation | -154 Thousand USD | 1035490.909% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 3189104.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -2077129.322% |
| IMV Inc. | -962.29 Thousand USD | 165797.32% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 411583.325% |
| MultiCell Technologies, Inc. | 49.32 USD | -3232972324.98% |
| ONE Bio Corp. | 20.12 Million USD | -7822.818% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -3860.02% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -3260640.286% |
| Q BioMed Inc. | -8988.00 USD | 17740442.679% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -5543.256% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 10337898.237% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -3494.636% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 139775.991% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -2277760.0% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 32199251.858% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 1635235.107% |
| GB Sciences, Inc. | -624.00 USD | 255529266.667% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 1853568.638% |
| HST Global, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 766587600.0% |
| Enzolytics Inc. | 30.7 Thousand USD | -5192364.504% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -330412.631% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | -43.846% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 310006.902% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -258167.464% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | -289.327% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 18004865.131% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 1901735.082% |
| Kadimastem Ltd | -630.13 Thousand USD | 253140.128% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -161289.946% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 13472867.216% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -902993.566% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -117389.609% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 5498382.759% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -354199.922% |
| SYBLEU INC | 11.69 Thousand USD | -13632783.037% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -34502.908% |
| Bioxytran, Inc. | -8285.00 USD | 19245748.763% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 427580.429% |
| Neutra Corp. | 14.33 Thousand USD | -11123039.17% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 1944614.634% |
| PureTech Health plc | -1.6 Million USD | 99569.869% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 159353.363% |
| IXICO plc | 3.27 Million USD | -48661.529% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 229855.331% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 89128.587% |
| CSL Limited | 7.7 Billion USD | 79.306% |
| Cellectis S.A. | 18 Thousand USD | -8858244.444% |